Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Environmental hazard testing of nanobiomaterials

  • Amorim, Mónica J. B.
  • Fernández-Cruz, M. L.
  • Hund-Rinke, K.
  • Scott-Fordsmand, J. J.
13 Pág., The European Medicines Agency (EMA) regards the potential risks of human medicinal products to the environment and their impacts are assessed, as well as management to limit this impact. Hazard assessment of novel materials, which differ from conventional chemicals, e.g. nanobiomaterials, poses testing challenges and represents a work-in-progress with much focus on the optimization of required methodologies. For this work-in-progress, we here highlight where changes/updates are required in relation to the main elements for international testing based on OECD guidelines, supported by knowledge from the nanotoxicity area. The outline describes two major sections, nanobiomaterials and environmental hazards, including its challenges and learned lessons, with recommendations for implementation in OECD guidelines. Finally, the way forward via a testing strategy is described.[Figure not available: see fulltext.]., This study was supported by the European Commission Project H2020-NMBP-2017 BIORIMA: BIOmaterial Risk MAnagement (GA No. 760928). Further support within H2020-NMBP-TO-IND-2018 NANORIGO: Establishing a NANOtechnology RIsk Governance Framework (GA No. 814530) and CESAM [UIDB/50017/2020 + UIDP/50017/2020], to FCT/MEC through national funds, and the co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

(Re)Conceptualizing decision-making tools in a risk governance framework for emerging technologies—the case of nanomaterials

  • Mullins, M.
  • Himly, M.
  • Rodríguez Llopis, I.
  • Furxhi, I.
  • Hofer, S.
  • Hofstätter, N.
  • Wick, P.
  • Romeo, D.
  • Küehnel, D.
  • Siivola, K.
  • Catalán, J.
  • Hund-Rinke, K.
  • Xiarchos, I.
  • Linehan, S.
  • Schuurbiers, D.
  • García Bilbao, A.
  • Barruetabeña, L.
  • Drobne, D.
The utility of decision-making tools for the risk governance of nanotechnology is at the core of this paper. Those working in nanotechnology risk management have been prolific in creating such tools, many derived from European FP7 and H2020-funded projects. What is less clear is how such tools might assist the overarching ambition of creating a fair system of risk governance. In this paper, we reflect upon the role that tools might and should play in any system of risk governance. With many tools designed for the risk governance of this emerging technology falling into disuse, this paper provides an overview of extant tools and addresses their potential shortcomings. We also posit the need for a data readiness tool. With the EUs NMP13 family of research consortia about to report to the Commission on ways forward in terms of risk governance of this domain, this is a timely intervention on an important element of any risk governance system.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Current status and future challenges of genotoxicity OECD Test Guidelines for nanomaterials: a workshop report

  • Doak, Shareen H
  • Andreoli, Cristina
  • Burgum, Michael J
  • Chaudhry, Qasim
  • Bleeker, Eric A J
  • Bossa, Cecilia
  • Domenech, Josefa
  • Drobne, Damjana
  • Fessard, Valérie
  • Jeliazkova, Nina
  • Longhin, Eleonora
  • Rundén-Pran, Elise
  • Stepnik, Maciej
  • El Yamani, Naouale
  • Catalán, Julia
  • Dusinska, Maria
Genotoxicity testing for nanomaterials remains challenging as standard testing approaches require some adaptation, and further development of nano-specific OECD Test Guidelines (TGs) and Guidance Documents (GDs) are needed. However, the field of genotoxicology continues to progress and new approach methodologies (NAMs) are being developed that could provide relevant information on the range of mechanisms of genotoxic action that may be imparted by nanomaterials. There is a recognition of the need for implementation of new and/or adapted OECD TGs, new OECD GDs, and utilization of NAMs within a genotoxicity testing framework for nanomaterials. As such, the requirements to apply new experimental approaches and data for genotoxicity assessment of nanomaterials in a regulatory context is neither clear, nor used in practice. Thus, an international workshop with representatives from regulatory agencies, industry, government, and academic scientists was convened to discuss these issues. The expert discussion highlighted the current deficiencies that exist in standard testing approaches within exposure regimes, insufficient physicochemical characterization, lack of demonstration of cell or tissue uptake and internalization, and limitations in the coverage of genotoxic modes of action. Regarding the latter aspect, a consensus was reached on the importance of using NAMs to support the genotoxicity assessment of nanomaterials. Also highlighted was the need for close engagement between scientists and regulators to (i) provide clarity on the regulatory needs, (ii) improve the acceptance and use of NAM-generated data, and (iii) define how NAMs may be used as part of weight of evidence approaches for use in regulatory risk assessments.